Schmitz et al. [18] have reported that p-ERK1/2 and p-Akt(ser473) are both highly expressed in HCC tissues, and that the activation of the ERK and AKT pathways predicts poor prognosis in HCC. This evidence concerns the gene MAPK3 and hepatocellular carcinoma.